Total Holdings
64
Portfolio diversification across 64 positions
IDNA
(NYSEARCA)iShares Genomics Immunology and Healthcare ETF
$29.25-- (--)
Loading... - Market loading
IDNA ETF Holdings: iShares Genomics Immunology and Healthcare ETF
Complete portfolio holdings with allocation weights, sector breakdown, and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Assets Under Management
$153.72M
Total fund assets
Expense Ratio
0.47%
Annual management fee
Fund Issuer
BlackRock
NYSEARCA
Portfolio Allocations
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
Top 45 Holdings by Portfolio Weight
View ticker symbols, company names, asset types, and allocation percentages for each position
Scroll to see more
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 |  | Moderna, Inc. | Stock | 6.75% |
| 2 |  | Revolution Medicines, Inc | Stock | 5.65% |
| 3 |  | Arcellx, Inc. | Stock | 5.36% |
| 4 | E EPA:IPN | Ipsen S.A. | Stock | 4.79% |
| 5 | T TYO:4502 | Takeda Pharmaceutical Company Limited | Stock | 4.62% |
| 6 |  | Merck & Co., Inc. | Stock | 4.44% |
| 7 | E ETR:BAYN | Bayer Aktiengesellschaft | Stock | 4.31% |
| 8 | T TSE:4502 | Takeda Pharmaceutical Co. Ltd. | Stock | 4.30% |
| 9 |  | Regeneron Pharmaceuticals, Inc | Stock | 4.21% |
| 10 | L LON:GSK | GSK plc | Stock | 4.16% |
| 11 | C CO:GMAB | Genmab A/S | Stock | 4.07% |
| 12 |  | Incyte Corporation | Stock | 3.96% |
| 13 |  | Vertex Pharmaceuticals Incorporated | Stock | 3.87% |
| 14 |  | Exelixis, Inc | Stock | 3.77% |
| 15 | S SWX:ROP | Roche Holding AG | Stock | 3.72% |
| 16 |  | Caris Life Sciences, Inc. Common Stock | Stock | 3.66% |
| 17 | E EPA:SAN | Sanofi | Stock | 3.54% |
| 18 |  | Ideaya Biosciences Inc | Stock | 3.49% |
| 19 |  | BioNTech SE | Stock | 3.40% |
| 20 | C CPH:GMAB | Genmab A/S | Stock | 3.07% |
| 21 |  | Twist Bioscience Corporation | Stock | 2.99% |
| 22 |  | ImmunityBio, Inc. | Stock | 2.74% |
| 23 |  | Nuvation Bio Inc | Stock | 2.14% |
| 24 | T TYO:4528 | Ono Pharmaceutical Co., Ltd. | Stock | 2.04% |
| 25 | T TSE:4528 | Ono Pharmaceutical Ltd | Stock | 1.92% |
| 26 |  | CRISPR Therapeutics AG | Stock | 1.86% |
| 27 |  | Arcus Biosciences, Inc | Stock | 1.75% |
| 28 |  | Novavax, Inc. | Stock | 1.30% |
| 29 |  | Iovance Biotherapeutics, Inc. | Stock | 1.26% |
| 30 |  | Kura Oncology Inc | Stock | 0.88% |
| 31 |  | Janux Therapeutics Inc | Stock | 0.85% |
| 32 |  | Rigel Pharmaceuticals Inc | Stock | 0.81% |
| 33 |  | CytomX Therapeutics, Inc | Stock | 0.62% |
| 34 |  | Vir Biotechnology, Inc | Stock | 0.61% |
| 35 |  | Pacific Biosciences of California, Inc | Stock | 0.58% |
| 36 |  | Verastem, Inc | Stock | 0.56% |
| 37 |  | Ocugen, Inc | Stock | 0.52% |
| 38 |  | Personalis, Inc | Stock | 0.48% |
| 39 | H HKG:2696 | Shanghai Henlius Biotech Inc | Stock | 0.45% |
| 40 |  | Ginkgo Bioworks Holdings Inc. | Stock | 0.44% |
| 41 |  | Corvus Pharmaceuticals Inc | Stock | 0.43% |
| 42 |  | Intellia Therapeutics, Inc | Stock | 0.43% |
| 43 |  | Xencor, Inc | Stock | 0.35% |
| 44 |  | Design Therapeutics, Inc. Common Stock | Stock | 0.33% |
| 45 |  | Prime Medicine Inc. Common Stock | Stock | 0.14% |
Frequently Asked Questions About iShares Genomics Immunology and Healthcare ETF Holdings
What are the top holdings in IDNA?
iShares Genomics Immunology and Healthcare ETF (IDNA) holds 64 securities. View the complete list of top holdings sorted by portfolio weight, showing each security's ticker symbol, company name, asset type, and allocation percentage.
How concentrated is IDNA's portfolio?
Portfolio concentration is measured by the weight of top holdings. A concentrated portfolio has fewer large positions with higher individual weights, while a diversified portfolio distributes holdings more evenly. Review IDNA's holdings table to analyze concentration risk.
What is IDNA's sector allocation?
The Sector Allocation chart shows how IDNA distributes investments across different industries like Technology, Healthcare, Financials, and more. This sector exposure helps understand the fund's industry diversification strategy.
What countries does IDNA invest in?
IDNA's geographic exposure is shown in the Countries tab under Portfolio Allocations. This reveals the fund's international diversification and exposure to different regions and global markets.
How diversified is IDNA ETF?
IDNA's diversification can be assessed by reviewing its 64 holdings, sector allocation, and geographic exposure. A well-diversified ETF spreads investments across multiple securities, sectors, and regions to reduce concentration risk.